These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20964620)
21. Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat. Song M; Hang TJ; Zhang Z; Chen HY Eur J Pharm Sci; 2007 Dec; 32(4-5):247-53. PubMed ID: 17942285 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Qiu F; Zhang R; Sun J; Jiye A; Hao H; Peng Y; Ai H; Wang G Drug Metab Dispos; 2008 Jul; 36(7):1308-14. PubMed ID: 18411400 [TBL] [Abstract][Full Text] [Related]
23. Development and validation of a high-throughput radiometric CYP3A4/5 inhibition assay using tritiated testosterone. Di Marco A; Marcucci I; Verdirame M; Pérez J; Sanchez M; Peláez F; Chaudhary A; Laufer R Drug Metab Dispos; 2005 Mar; 33(3):349-58. PubMed ID: 15608130 [TBL] [Abstract][Full Text] [Related]
24. Hydroxylation of tanshinone IIa in human liver microsomes is specifically catalysed by cytochrome P4502A6. Liu HX; Hu Y; Liu Y; He YQ; Li W; Yang L Xenobiotica; 2009 May; 39(5):382-90. PubMed ID: 19387893 [TBL] [Abstract][Full Text] [Related]
25. Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. Ueng YF; Kuo YH; Wang SY; Lin YL; Chen CF Life Sci; 2004 Jan; 74(7):885-96. PubMed ID: 14659977 [TBL] [Abstract][Full Text] [Related]
26. Simultaneous purification of dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA from Salvia miltiorrhiza and their anti-inflammatory activities investigation. Gao H; Huang L; Ding F; Yang K; Feng Y; Tang H; Xu QM; Feng J; Yang S Sci Rep; 2018 May; 8(1):8460. PubMed ID: 29855534 [TBL] [Abstract][Full Text] [Related]
27. Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450. Choi MH; Skipper PL; Wishnok JS; Tannenbaum SR Drug Metab Dispos; 2005 Jun; 33(6):714-8. PubMed ID: 15764715 [TBL] [Abstract][Full Text] [Related]
28. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752 [TBL] [Abstract][Full Text] [Related]
29. Meclizine, a pregnane X receptor agonist, is a direct inhibitor and mechanism-based inactivator of human cytochrome P450 3A. Foo WY; Tay HY; Chan EC; Lau AJ Biochem Pharmacol; 2015 Oct; 97(3):320-30. PubMed ID: 26239802 [TBL] [Abstract][Full Text] [Related]
30. Impact of organic solvents on cytochrome P450 probe reactions: filling the gap with (S)-Warfarin and midazolam hydroxylation. González-Pérez V; Connolly EA; Bridges AS; Wienkers LC; Paine MF Drug Metab Dispos; 2012 Nov; 40(11):2136-42. PubMed ID: 22896727 [TBL] [Abstract][Full Text] [Related]
31. Drug interaction of efavirenz and midazolam: efavirenz activates the CYP3A-mediated midazolam 1'-hydroxylation in vitro. Keubler A; Weiss J; Haefeli WE; Mikus G; Burhenne J Drug Metab Dispos; 2012 Jun; 40(6):1178-82. PubMed ID: 22415932 [TBL] [Abstract][Full Text] [Related]
32. Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide). Tseng E; Walsky RL; Luzietti RA; Harris JJ; Kosa RE; Goosen TC; Zientek MA; Obach RS Drug Metab Dispos; 2014 Jul; 42(7):1163-73. PubMed ID: 24737844 [TBL] [Abstract][Full Text] [Related]
33. Ethanol inhibits in-vitro metabolism of nifedipine, triazolam and testosterone in human liver microsomes. Patki KC; Greenblatt DJ; von Moltke LL J Pharm Pharmacol; 2004 Aug; 56(8):963-6. PubMed ID: 15285839 [TBL] [Abstract][Full Text] [Related]
34. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245 [TBL] [Abstract][Full Text] [Related]
35. Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil. Wang YH; Jones DR; Hall SD Drug Metab Dispos; 2005 May; 33(5):664-71. PubMed ID: 15689501 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of tanshinone IIA and cryptotanshinone in platelet anti-aggregating effects: an integrated study of pharmacology and computational analysis. Maione F; Cantone V; Chini MG; De Feo V; Mascolo N; Bifulco G Fitoterapia; 2015 Jan; 100():174-8. PubMed ID: 25497578 [TBL] [Abstract][Full Text] [Related]
37. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9. Wang R; Zhang H; Wang Y; Yu X; Yuan Y J Ethnopharmacol; 2016 Mar; 180():87-96. PubMed ID: 26806573 [TBL] [Abstract][Full Text] [Related]
38. Cyp3a deficiency enhances androgen receptor activity and cholesterol synthesis in the mouse prostate. Hashimoto M; Kobayashi K; Yamazaki M; Kazuki Y; Takehara S; Oshimura M; Chiba K J Steroid Biochem Mol Biol; 2016 Oct; 163():121-8. PubMed ID: 27137100 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study of a standardized fraction of Salvia miltiorrhiza, PF2401-SF. Park EJ; Ji HY; Kim NJ; Song WY; Kim YH; Kim YC; Sohn DH; Lee HS Biomed Chromatogr; 2008 May; 22(5):548-55. PubMed ID: 18205136 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail. Lee E; Shon JC; Liu KH Biopharm Drug Dispos; 2016 Sep; 37(6):366-72. PubMed ID: 27323294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]